⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL17491666 | 1.00 | ALDH1A1 (0.41) | — | |
| Ether SCHEMBL7426333 | 1.00 | ALDH1A1 (0.41) | — | |
| Ether SCHEMBL16111404 | 1.00 | ALDH1A1 (0.41) | — | |
| Ether SCHEMBL5738680 | 1.00 | ALDH1A1 (0.41) | — | |
| Ether SCHEMBL2785286 | 1.00 | ALDH1A1 (0.41) | — | |
| Ether SCHEMBL7600629 | 1.00 | ALDH1A1 (0.41) | — | |
| Ether SCHEMBL5740091 | 1.00 | ALDH1A1 (0.41) | — | |
| Ether SCHEMBL7076838 | 1.00 | ALDH1A1 (0.41) | — | |
| Ether SCHEMBL2639432 | 0.95 | ALDH1A1 (0.39) | — | |
| Ether SCHEMBL8708261 | 0.91 | ALDH1A1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110236709-A | A kind of novel orthodontic method | 苏州博思美医疗科技有限公司 | 2019-09-17 | — | — | CN | claimed |
| CN-102030809-A | Theasapogenol derivative with antibacterial effect as well as preparation method and application thereof | UNIV SOUTH CHINA TECH | 2011-04-27 | — | — | CN | claimed |
| EP-4355748-A1 | SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | SANOFI (FR) | 2024-04-24 | — | — | EP | disclosed |
| EP-3466934-B1 | SULFONAMIDE COMPOUNDS OR SALT THEREOF AS RIBONUCLEOTIDE REDUCTASE INHIBITORS FOR TREATING CANCER | TAIHO PHARMACEUTICAL CO LTD (JP) | 2024-03-27 | — | — | EP | disclosed |
| WO-2024052685-A1 | CYTOTOXIC IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY | MyricX Pharma Limited (GB) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024052684-A1 | ANTIBODY DRUG CONJUGATE COMPRISING NMT INHIBITOR AND ITS USE | MyricX Pharma Limited (GB) | 2024-03-14 | — | — | WO | disclosed |
| US-20240051951-A1 | BICYCLIC COMPOUND AND USE THEREOF | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2024-02-15 | — | — | US | disclosed |
| WO-2023196157-A1 | SILICONE-SOLUBLE ACYLPHOSPHINE OXIDE PHOTOINITIATOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-10-12 | — | — | WO | disclosed |
| WO-2023196158-A1 | ACYLPHOSPHINE OXIDE PHOTOINITIATOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-10-12 | — | — | WO | disclosed |
| WO-2023183613-A2 | INDOLIZINE COMPOUNDS FOR THE TREATMENT OF MENTAL DISORDERS OR INFLAMMATION | TACTOGEN INC (US) | 2023-09-28 | — | — | WO | disclosed |
| US-20230286965-A1 | BICYCLIC COMPOUND AND USE THEREOF | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| WO-1991002741-A1 | SUGAR ALCOHOL DERIVATIVES, A PROCESS FOR PREPARING 3-DEOXY-2-OCTULOSONIC ACID AND 3-DEOXY-2-HEPTULOSONIC ACID COMPOUNDS AND DERIVATIVES | RIJKSUNIVERSITEIT TE LEIDEN (NL) | 1991-03-07 | — | — | WO | disclosed |
| EP-0054795-B1 | NOVEL HALOGENATED PROSTACYCLINS, PROCESS FOR THE PRODUCTION THEREOF, AND PHARMACEUTICAL USE THEREOF | TEIJIN LIMITED (JP) | 1987-07-15 | — | — | EP | disclosed |
| US-4472428-A | CARDIOVASCULAR DISORDERS, ORGAN TRANSPLANTS | TEIJIN LIMITED (JP) | 1984-09-18 | — | — | US | disclosed |
| EP-0054795-A2 | Novel halogenated prostacyclins, process for the production thereof, and pharmaceutical use thereof | TEIJIN LIMITED (JP) | 1982-06-30 | — | — | EP | disclosed |
| US-4105676-A | 2-ALKOXY ETHYL-6-/3-CYANOPROPYL/TETRAHYDROPYRAN-2-OL | HOFFMANN-LA ROCHE INC. (US) | 1978-08-08 | — | — | US | disclosed |
| US-3994930-A | MULTISTEP, STEREOSPECIFIC TOTAL SYNTHESIS OF STEROIDS | HOFFMANN-LA ROCHE INC. (US) | 1976-11-30 | — | — | US | disclosed |
| US-3991084-A | Steroid total synthesis process utilizing a cyanoalkyl A-ring precursor | HOFFMANN-LA ROCHE INC. (US) | 1976-11-09 | — | — | US | disclosed |
| US-3965138-A | Steroid total synthesis process utilizing a cyanoalkyl A-ring precursor | HOFFMANN-LA ROCHE INC. (US) | 1976-06-22 | — | — | US | disclosed |
| US-3931279-A | 5-Oxa prostaglandin F2.sub.α analogs | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | disclosed |